Phase I Clinical Trial Examines Safety of Using Cord Blood Stem Cells for Treating Children with Autism Spectrum Disorder

Preliminary Findings Indicate Potential Efficacy of Cord Blood to Improve the Lives of Children with Social and Behavioral Challenges Associated with ASD WALTHAM, Mass. –  April 5, 2017–  Novel research results from Duke University’s Robertson Clinical and Translational Cell Therapy Program published today in the April issue of Stem Cells Translational Medicine indicate promising developments... Read more

Rigaku Launches the SmartLab SE Multipurpose X-ray Diffractometer with Built-in Intelligent Guidance

Rigaku introduces new multipurpose X-ray diffraction system with built-in intelligent guidance to optimize hardware configuration and settings for specific application measurements TOKYO, April 4, 2017 /PRNewswire/ — Rigaku Corporation is pleased to announce the release of the Rigaku SmartLab SE system, a highly versatile multipurpose X-ray diffractometer with built-in intelligent guidance. The SmartLab® SE system offers... Read more

Seven Bridges Announces Strategic Partnership With Spatial Transcriptomics

Relationship Aims to Advance Development of Innovative Tools for Visualizing and Analyzing Gene Expression within Tissue Samples April 4, 2017 CAMBRIDGE, Mass., April 4, 2017 –Seven Bridges, the biomedical data analysis company, today announced an investment in Spatial Transcriptomics, a life sciences start-up developing innovative technology to analyze tissue samples and gene expression data in... Read more

Paragon Genomics Launches its CleanPlex (TM) Target Enrichment Solution at AACR 2017

NEWS PROVIDED BY Paragon Genomics Apr 04, 2017, 14:11 ET SHARE THIS ARTICLE WASHINGTON, April 4, 2017 /PRNewswire/ — AACR 2017 — Paragon Genomics, a life science company dedicated to improving the critical upfront target enrichment and library preparation workflow for Next-Generation Sequencing, is launching its CleanPlex™ target enrichment solution. It is a patented amplicon sequencing technology, debuting at AACR Annual Meeting 2017 together with its... Read more

Xylem increases its 2020 financial targets and reaffirms its strategy to reflect accelerated growth driven by acquisitions

Company also reaffirms full-year 2017 guidance RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 4, 2017– At its Investor Day in Raleigh-Durham, North Carolina, Xylem (NYSE:XYL), a leading global water technology company, today will update its 2020 financial guidance and showcase the broad portfolio of smart infrastructure technologies and solutions provided by its Sensus and Visenti businesses. Xylem acquired... Read more